Aducanumab

Uncategorized

Aducanumab

What is Aducanumab
?

Aducanumab is a humanized monoclonal antibody that is designed to target and clear senescent cells from the body. It is currently under development as a potential treatment for age-related diseases and disorders.

Benefits of Aducanumab
and Its Uses.

Aducanumab is a monoclonal antibody that is used to treat Alzheimer’s disease. It is a humanized antibody that is designed to clear amyloid beta plaques from the brain. Amyloid beta plaques are believed to play a role in the development of Alzheimer’s disease.

Aducanumab is currently in Phase III clinical trials. It is not yet approved by the FDA for the treatment of Alzheimer’s disease. However, the results of the Phase III trials are expected to be released in early 2019.

The results of the Phase III trials are expected to be released in early 2019.

If the Phase III trials are successful, aducanumab could be approved by the FDA for the treatment of Alzheimer’s disease in early 2020.

Side Effects and Dosage of Aducanumab

Aducanumab is a monoclonal antibody that is used for the treatment of Alzheimer’s disease. It is given as an injection under the skin.

Common side effects of aducanumab include:

headache

nausea

vomiting

diarrhea

pain in the arms or legs

These are not all of the possible side effects of aducanumab. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Dosage of aducanumab is based on your weight, medical condition, and response to treatment.

Do not stop taking aducanumab without talking to your doctor.

Category: Uncategorized
Posts created 12429

Leave a Reply

Your email address will not be published.

Related Posts

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top